Randox listed on Gov.uk as provider of Day 2 Lateral Flow COVID tests
Randox listed on Gov.uk as provider of Day 2 Lateral Flow COVID tests
22nd October 2021: Randox listed on Gov.uk as provider of Day 2 Lateral Flow COVID tests
Following changes to government travel guidance, lateral flow (antigen) tests will be the Day 2 requirement for any fully vaccinated passengers arriving into England, from 24th October. This change applies only to fully vaccinated international travellers and most under 18s arriving into England from non-red list countries, and will replace the previous PCR testing requirement.
This change will come into effect for anyone returning into England, following the half-term break and tests can be completed on or before day two of their arrival.
Randox is listed on Gov.uk as a provider of Day 2 Lateral Flow COVID tests.
Randox offers multiple lateral flow testing solutions, including the new Randox CertiFly rapid antigen test, which will allow you to complete your Day 2 test in the comfort of your own home from only £19.99.
The Randox CertiFly Lateral Flow test is designed to simplify foreign travel for passengers and facilitate the efficient transfer of secure and verified information through an easy to use mobile app.
Available for free through the App Store and coming soon on Google Play, the app securely identifies customers and processes testing results within 3 hours.
To order a Lateral Flow Home Testing Kit visit https://covid.randox.com/day-2-test-at-home/
If your preference is to take your Day 2 test on arrival at the airport then you have the option of visiting one of our many travel centres conveniently located across the UK.
From £35 you can organise for a Sample Collection Officer to take your swab at clinics including Manchester Airport, Heathrow Airport, Stansted Airport, East Midlands Airport, Liverpool ONE, and Waterloo Station London.
To book an in-clinic Day 2 Lateral Flow appointment visit https://covid.randox.com/day-2-test-in-clinic/
Background to Government changes
Eligible fully vaccinated arrivals and those with an approved vaccine from non-red countries will be able to replace the test taken as soon as possible on arrival, referred to as the Day 2 PCR test, with a self-administered lateral flow device (“LFD”). Arrivals must have had a complete course of a recognised vaccine at least 14 days before arriving in England. They will not be required to take a Pre-Departure Test or a Day 8 test.
Passengers who do not meet the “eligible traveller” criteria will still have to take a pre-departure test, a Day 2 and Day 8 PCR test and self-isolate for 10 days upon their return from a non-red list country. Test to Release will remain an option for unvaccinated passengers who wish to shorten their isolation period.
How will the new lateral flow system work?
Passengers will be required to take a photograph of their completed lateral flow test alongside their booking reference number which Randox will provide via email on receipt of order. Randox will then verify the result of your sample. Passengers will still be required to complete a passenger locator form to return to England.
Anyone who tests positive will be required to self-isolate and take a confirmatory PCR test. The government have confirmed that anyone who has previously purchased a Randox PCR test will not need to buy another lateral flow (antigen) test.
With proven testing capability and well-established logistics and customer support services, Randox is strongly placed to allow all travellers to the UK to complete their antigen test with ease – offering same day results up to 11.59pm.
For further information on our Day 2 Lateral Flow testing please click here.
To read more on official UK government announcement please click here.
For customer enquiries please contact our Customer Support team on 028 9434 3005.
Related COVID-19 Products and Services
CERTIFLY LATERAL FLOW
HOME TEST - PCR
ANTIBODY TEST
LABORATORY TOOLS
Randox receives UKAS ISO 17025 Accreditation for testing of SARS-CoV-2 (COVID-19)
Randox receives UKAS ISO 17025 Accreditation for testing of SARS-CoV-2 (COVID-19)
Randox Laboratories has today confirmed its UKAS ISO 17025 accreditation for the detection of the SARS-CoV-2 virus (COVID-19), granted on 7th October 2021.
UKAS is the National Accreditation Body for the United Kingdom and is appointed by government to assess and accredit organisations that provide testing services. Given the unprecedented requirement for nationwide testing over the past two years, the need for the public to have confidence in testing remains more important than ever.
Randox has been at the forefront of COVID-19 testing since the outset of the pandemic, is amongst the very largest COVID-19 laboratories in the UK and Europe, and to date has processed almost 20 million tests.
Today this final UKAS documentation confirms that Randox has continuously met all ongoing Government and UKAS requirements and submission deadlines, to remain fully active as a national COVID-19 testing provider, and listed on the Gov.uk website.
Randox, with almost 40 years of diagnostics experience, and multiple UKAS accreditations for a range of testing methods, is well placed to support the testing requirements associated with international travel.
To order a Randox home test kit visit covid.randox.com
For any enquiries on our Covid testing services please contact the Randox Covid Customer Support team on +44 (0) 28 9434 3005.
Related COVID-19 Products and Services
CERTIFLY LATERAL FLOW
HOME TEST - PCR
ANTIBODY TEST
LABORATORY TOOLS
Health Minister Robin Swann visits Randox COVID testing laboratories
20th October 2021: Health Minister Robin Swann visits Randox COVID testing laboratories
Health Minister Robin Swann has today thanked local staff for their ongoing role in COVID-19 testing while visiting Randox Laboratories.
During his visit to the testing facility at Randox Science Park on the outskirts of Antrim, the Health Minister heard how the company significantly increased its testing capacity since the beginning of the pandemic.
Following a tour of the facility, Minister Swann, said: “Randox continues to play an important ongoing role in the fight against COVID-19 as part of the National Testing Programme and has enabled thousands of people in Northern Ireland to get tested quickly.
“There is no doubt, that we are in a very fortunate position in Northern Ireland to have companies like Randox. We have seen how the company and its highly skilled and expert workforce have been able to innovate and advance its testing capabilities to greatly support the pandemic. I want to personally thank the staff at Randox for all they have done in helping to keep people safe.”
Minister Swann added: “We are continuing to see a high number of positive cases each day in Northern Ireland which is concerning. Therefore I would again remind people of the importance of getting tested should they develop symptoms. Alongside vaccination and contact tracing, COVID-19 testing remains one of the main pillars of protection against this virus. Please do the right thing.”
Dr Peter FitzGerald, Randox Managing Director said:
“We are delighted to welcome Minister Swann to our COVID testing laboratories at the Randox Science Park in Antrim, to witness first-hand the incredible efforts of our hard-working staff, who have been at the forefront of COVID-19 testing since the outset of the pandemic and as such have played a vital role in the global fight against coronavirus.
“Thanks to their ongoing commitment to serve our communities in these difficult times, Randox remains amongst the very largest COVID-19 laboratories in the UK and Europe, and to date has processed almost 20 million tests for the UK National Testing Programme and testing for international travel.
“Randox have built on 40 years of diagnostic experience, and extensive R&D, to provide our extensive COVID-19 testing capabilities and we will continue to support the community and the needs of travellers for as long as that is required. Thereafter we know that diagnostics have a key role in future healthcare, to both prevent disease and optimise its treatment, and will refocus our efforts to that end.”
Since March 2020, Randox has invested a total of £150 million in the development of new innovations in testing technology and in the building and equipping of world-class testing laboratories, sample collection clinics, and associated logistics networks. The company has also grown its workforce by more than 850, and continues to recruit across science, manufacturing and customer support.
For further information please contact Amy Millar, Randox Public Relations Team Leader; amy.millar@randox.com or 028 9442 2413
Related COVID-19 Products and Services
CERTIFLY LATERAL FLOW
HOME TEST - PCR
ANTIBODY TEST
LABORATORY TOOLS
We Are Randox | Randox IT is shortlisted in the Belfast Telegraph IT Awards 2021
19 October 2021: Randox IT Team is shortlisted in the Belfast Telegraph IT Awards 2021
Congratulations to the Randox IT department who have been shortlisted in four categories at the Belfast Telegraph IT Awards 2021.
The event from the Belfast-based media outlet, is set to be a showcase of the finest that the Northern Ireland IT industry has to offer with both IT agencies and in-house IT teams vying for the chance to be crowned among the best their respective fields.
Randox IT have been shortlisted for Digital Project of the Year, IT Team of the Year, IT Project Team of the Year, and Covid Response for their work on the development of IT systems required for nationwide COVID testing, playing a critical role in the fight against COVID-19.
See an overview of their applications below.
In early 2020 Randox, the largest diagnostics company from the UK, recognised the threat from COVID-19 and based on almost 40 years of experience, developed a test to identify the virus in a greatly accelerated timeframe of just two weeks.
Faced with unprecedented demand for testing to curb the spread of the virus, the company stepped up to support the UK Government’s National COVID-19 Testing Programme without hesitation.
Armed with world-leading testing technology and expertise, the next step for Randox was to scale its capacity and infrastructure.
Growing from an initial testing capacity of just 150 samples on the first day of COVID testing in March 2020, to now a capacity of 500,000 COVID samples per day, Randox has to date tested almost 20 million samples across the National Testing Programme and private testing for international travel.
These accomplishments would not have been possible without the Randox IT team, who responded quickly in an ever-evolving situation and introduced a full end-to-end testing process inclusive of logistics, sample registration, accessioning and results reporting, for tens of thousands of daily tests.
The development of platforms such as an online sample kit registration portal, intelligent robotics automation, and an informatic lab workflow management system, all designed and developed entirely in-house, showcases the knowledge, expertise, responsiveness and overall capability within Randox IT.
Examples of innovative systems developed in-house by the Randox IT team include but are not limited to;
- Online sample collection kit registration portal
- Robust accessioning platform for sample receipt and chain of custody
- End-to-end digital and informatic laboratory workflow management solution
- Robotics for intelligent process automation
- Fully automated result communication system
- Intelligent data management
- Diagnostic algorithm development
Each of these innovative and re-deployable platforms has been scaled across a number of different testing services. Initially intended for Randox’s new 80,000 sqft of molecular laboratory space at the company’s headquarters in Antrim, the systems are also in use across newly built adaptive labs in Manchester and London, in mobile testing vans at key airport locations, and in a number of walk-through and drive-through testing clinics across the UK and Ireland.
The improvements in IT automation, robotics and software capabilities, have enabled Randox to upscale its testing capability like no other – growing the company to be amongst the largest COVID-19 testing laboratories in Europe.
The finals for the Belfast Telegraph IT Awards 2021 will take place on Friday 5th November 2021 in The Mac, Belfast and all finalists can be viewed here.
Good luck to the Randox IT department!
Find out more about Randox Careers
Careers News
Vacancies
Our Team
Staff Profiles
Largest COVID PCR testing provider announces new nationwide network of āadaptiveā labs
Tuesday 28 September 2021: Largest COVID PCR testing provider announces new nationwide network of ‘adaptive’ labs
Randox, the UK’s largest laboratory diagnostics company, today announces its most significant expansion to date – the opening of 10 new adaptive “cube” laboratories within Great Britain. These facilities provide a rapid and cost-effective model to expand laboratory provision. They will improve accessibility to Covid testing, facilitate wider screening services and adapt to future health and testing challenges. Based on a modular format, sites can be operational within weeks and be redeployed if required.
The laboratories will initially be used to enhance the UK’s COVID-19 testing capacity during the winter, with each lab’s daily capacity of 12,000 tests combining to bring online an additional 120,000 COVID samples per day. They can subsequently be re-purposed to meet the UK’s post COVID diagnostic requirements.
The opening of the new laboratories, which upon completion, will create 700 new jobs across the UK, follows £30 million of investment by Randox, bringing its total COVID-19 investment to £150 million. Two of Randox’s ten new labs are already operational outside Manchester, with two sites to the north of London opening before the end of the month. Following this, a further six labs are set to open by the end of 2021.
Commenting on the announcement Dr Peter FitzGerald, Randox Managing Director, said;
“Whilst the initial emphasis of these new laboratories will be on providing accessible, reliable and cost-effective COVID PCR tests, we of course acknowledge the positive steps being taken to ease restrictions and continue opening up our economy.
“We can draw on what we have learnt both pre and during COVID, leveraging the extensive logistics framework and IT infrastructure we have put in place, to directly address the global shortfall in laboratory testing capacity that has been exposed by the pandemic.
“The time taken to establish the required diagnostic infrastructure in the early stages of the pandemic adversely impacted the international response, but with such an adaptable capability, the UK can, as and when needed, respond rapidly to ever-increasing diagnostic demand.”
The new adaptive laboratories from Randox will ensure the provision of travel testing for those who still require them, and can also support any surge testing for the UK’s National COVID Testing Programme; Randox has processed and reported over 18 million COVID PCR samples to date. Randox also facilitate Covid-19 lateral flow testing.
Having used its 40 years’ experience in diagnostics to focus the business towards COVID testing and support the fight against the virus, Randox, established in 1982, will subsequently use its new lab sites to service a wider UK system of walk-in clinics which can offer whole-body diagnostic screening programmes.
Dr FitzGerald continued;
“The legacy of COVID is that people increasingly understand and appreciate the importance of diagnostics and testing across our society, and as such we anticipate a real appetite from people to take greater interest in their health.
“We will continue COVID testing where necessary but will harness this high-volume testing capacity to pivot back to our core business offering of clinical health tests. The investment we have made in COVID lab facilities will allow us to build a national testing network that will facilitate a shift towards a new era of preventative healthcare, in which ill-health and disease are detected at the earliest possible opportunity, potentially even before symptoms appear.
“Our new adaptive laboratories will fundamentally be a game-changer for the UK’s future diagnostics requirements – improving patient outcomes and reducing the burden on healthcare services.”
For further information on Covid testing services please contact the Randox Covid Customer Support team on covidcustomersupport@randox.com or +44 (0) 28 9434 3005.
Want to know more?
Contact us or visit Randox Health.
Related COVID-19 Products and Services
PRE DEPARTURE
ANTIBODY TEST
DAY 2 TEST
LABORATORY TOOLS
Why does Randox sponsor Equine Sports events?
Why does Randox sponsor Equine Sports?
1 September 2021: Why does Randox sponsor Equine Sports?
Some may be wondering, why is a healthcare company so invested in the equine industry? Why would they sponsor the world’s most famous steeplechase – The Randox Grand National?
It’s a labour of love… Peter FitzGerald’s fond attachment to the equestrian world, together with 40 years’ experience in the in vitro diagnostics industry, was the perfect match.
Clinical diagnostics is at the heart of Randox and our experience and expertise has paved the way for the development of innovative and accurate diagnostic products for Equine Health.
You could say ‘it runs in our blood.’
With 70% of all medical decisions based on the analysis of blood, Randox are set to release the VeraSTAT-V, a stable-side Equine Serum Amyloid A test device designed to detect levels of inflammation in horse blood in a matter of minutes.
The ability to quickly detect and monitor your horse’s health, at the stable side, brings huge benefits to both horse and owner. Early detection of inflammatory states means treatment plans can start sooner, recovery periods are shorter, and the horse can return to work healthy much earlier.
When performance is key, monitoring inflammation is vital.
Whether it’s detecting inflammation related to joint injury, or screening for infection before or after transport, competition or surgery, the VeraSTAT-V is a valuable means to monitor Equine Health.
At Randox, we have enjoyed a long-standing partnership with the Jockey Club and will continue to deliver innovative diagnostics solutions to the Equine Industry for the years ahead.
Interested in finding out more?
For all Equine SAA and/or Veterinary related inquiries, please email marketing@randox.com or visit www.randox.com/veraSTAT-V for more information.
QUALITY CONTROL
REAGENTS
RX SERIES
Collinson and Randox partner to launch rapid airport PCR for travel testing
Tuesday 07 September 2021: Collinson and Randox partner to launch rapid airport PCR for travel testing
Rapid PCR technology means passengers can receive results in under three hours on the day of departure
Collinson has today announced it has partnered with biotech company, Randox, to offer rapid PCR testing. The ground-breaking new testing offering, which is already available at Collinson’s new park and test facility near Heathrow Airport, uses advanced on-site Randox technology to process RT-PCR – the gold standard of Covid-19 virus testing – in under three hours. It means passengers who require a negative PCR result to fly can, for the first time, book to take the test on their day of departure and have their result in time for check-in, rather than needing to arrange for a test days in advance.
Today’s announcement from Collinson and Randox will make the PCR testing process far more seamless for passengers, enabling them to book to take their test as part of the journey to the airport. In the next few weeks, the new technology will also be launched at Collinson’s drive-through facility near Gatwick.
With testing numbers skyrocketing as more people look to get abroad in line with UK restrictions lifting, Collinson is launching the rapid Randox testing as another option to help meet increased demand. Collinson has been a front-runner in travel testing solutions across the UK since it launched its first facility last summer and led the way in getting rapid genetic LAMP testing technology accredited for ‘Day 5’ testing.
Today’s partnership with Randox combines the medical and biological expertise and experience both companies have gained in travel testing over the past year. The joining of the two British companies and this new, rapid PCR technology means cheaper, faster and more reliable same day testing for anyone departing from the UK, which is sure to be a boost to both the country’s travel industry recovery as well the UK’s trade in general.
This new offering means that passengers with bookings can take a rapid PCR test the day they travel. As processing is handled on site rather than couriered to a lab; it is quicker while being just as reliable. While awaiting their test result, passengers can proceed to the airport terminal and enjoy a coffee, before going to check-in.
“We’ve come such a long way in travel testing since we first started speaking to the UK Government about our solutions last summer,” said Dr. Simon Worrell, Global Medical Director, Collinson. “The new, rapid PCR tests we’re announcing with Randox today really are the most sophisticated tests on the market. No longer do travellers need to take a PCR test three days before travel, and so risk contracting the virus in the interim. They’re a complete game-changer for anyone looking to travel at this time, making the testing process as seamless as possible for passengers as they can conveniently take their test on their way to the airport, rather than needing to find somewhere to be tested days in advance.”
“We are pleased to have partnered with Collinson, which has been leading the way in travel testing and recovery since last summer,” said David Ferguson, Managing Director, Randox. “We at Randox have been on the front line in the fight against COVID-19 since its outbreak last year and both of our companies know how important testing is to travel recovery. We’re thrilled to come together to pioneer rapid PCR testing – once more doing our bit to get the travel industry back on its feet and the world moving once more. This partnership allows Randox to further advance its service delivery in the fight against Covid-19 and offer ground-breaking medical diagnostics to ensure rapid and effective PCR testing. Travel during the pandemic has undoubtedly been challenging, but with this partnership I am confident that travel will now be far more accessible and achievable to those who use this service.”
The cost of a rapid PCR test is £95. To book visit collinsongroup.com
As a UKAS-approved testing provider, in addition to RT-PCR tests, Collinson will continue to offer a range of COVID-19 testing solutions for pre-departure and post-arrival at its facilities nationwide. Destination entry requirements differ depending on whether you are fully vaccinated or not. Travellers should check the entry requirements of their intended destination country using the GOV.UK foreign travel advice pages to be confident in their requirements.
Randox, with almost 40 years of international diagnostics experience, has been at the forefront of COVID-19 testing since the outset of the pandemic. With proven testing capability and well-established logistics and customer support services, Randox are strongly placed to allow international travellers to travel with confidence.
For further information on Covid testing services please contact the Randox Covid Customer Support team on +44 (0) 28 9434 3005.
Want to know more?
Contact us or visit Randox Health.
Related COVID-19 Products and Services
HOME TEST
ANTIBODY TEST
TEST TO RELEASE
LABORATORY TOOLS
Massive operation launched to keep ParalympicsGB team COVID-free
Sunday 15 August 2021: Massive operation launched to keep ParalympicsGB team COVID-free
A huge, high-tech operation is now under way to ensure that the 600-strong ParalympicsGB delegation touches down in Tokyo next weekend free of COVID and that athletes have the best possible opportunity to compete without the fear of being ruled out on health grounds.
The ‘stop the virus’ logistics drive mirrors a similar and highly successful regime which ensured that Team GB landed in Japan COVID-free and that no athlete was then forced to withdraw in Tokyo because of infection or close contact with someone who had tested positive.
Despite fears that the virus could impact Team GB’s Olympic hopes, the rigorous testing programme put in place helped UK sporting stars to rack up 65 medals – their best-ever performance at an overseas Games bar the 67 medals won at Rio in 2016.
The COVID-19 testing programme is being masterminded by ParalmypicsGB with the support of Randox, which has the biggest COVID testing labs in the UK and Ireland, and amongst the biggest in Europe.
British competitors in the Tokyo 2020 Paralympic Games will be tested regularly before they fly to Japan, with the last test just 72 hours before departure.
As with the Team GB Olympics operation, Randox is delivering test kits direct to athletes, either at their homes or training camps, and has set up its own courier services to ensure speed and reliability in processing the results.
ParalympicsGB will have visibility of a bespoke dashboard to register, view and access results reports for samples that will be taken by the ParalympicsGB Clinical Team and then transported to and tested in Randox’s COVID-19 laboratories, capable of processing 500,000 samples per day.
Whilst out in Tokyo from 24 August – 5 September the ParalympicsGB delegation of over 600 athletes, coaches and support staff will also have access to unique Randox point-of-care technology which offers rapid PCR tests results in as little as 40 minutes – an extra layer of safety that will provide the team with further reassurance that they are COVID-free while competing.
Randox Managing Director, Dr Peter FitzGerald, said;
“Following our testing regime for Team GB who enjoyed an incredibly successful Tokyo 2020 Olympic Games, we are delighted we can extend our gold-standard PCR testing to the ParalympicsGB athletes ahead of their competing in the Paralympics.
“It is an honour to provide our COVID-19 testing service to ParalympicsGB, so the athletes can travel to Tokyo to achieve their dream of competing in the sport they have trained so hard for, and we can help to keep them safe along the way.”
Four-time Paralympic Gold Medallist Bethany Firth MBE will be using Randox Health’s COVID-19 testing service for safe travel to and from the Tokyo 2020 Paralympic Games
Not only is Randox trusted by the British Olympic and Paralympic Associations to deliver reliable and timely testing but it is also recognised across the UK and Ireland for its efficient returns service, a unique and independent logistics operation consisting of a network of more than 120 custom-built dropboxes to which customers, and BPA Paralympians, can deposit their samples for next-day results.
One such Paralympian is Northern Irish swimmer Bethany Firth, a four-time Paralympic gold medallist who was Great Britain’s most successful Paralympian, with three golds and a silver medal, at the 2016 Paralympic Games in Rio, and who will be using Randox Health’s COVID-19 testing service for safe travel to and from the Tokyo 2020 Paralympic Games.
Four-time Paralympic Gold Medallist Bethany Firth MBE said;
“The journey to the Tokyo 2020 Paralympic Games has been an incredibly challenging one, as I had been previously recovering from an injury and taking a break from heavy training. When the time came to get back to Paralympic preparation the COVID pandemic hit and all of a sudden I no longer had the option to train in the way I have been since I began to swim.
“At various points throughout the last year I and my fellow Para Swimmers even wondered if we would make it out to Tokyo, spending our days during lockdown swimming in our paddling pools in our back gardens because we couldn’t access a pool.
“I am therefore so grateful to Randox Health for providing Paralympics GB with the COVID-19 testing we need to compete in Tokyo in a safe and COVID-free assured environment, and for enabling me to continue on to the next stage of my swimming and Paralympic journey.”
British Paralympic Association CEO Mike Sharrock said;
“The health and wellbeing of athletes is always the top priority for ParalympicsGB. To ensure we get our team to the Tokyo 2020 Paralympic Games for this pinnacle moment in their sporting careers, we must first do all we can to prioritise their safety and wellbeing so that they can board the plane to Japan.
“By partnering with a testing supplier of Randox Health’s calibre we can be assured we have the highest quality COVID-19 testing available – giving the athletes the peace of mind they need to focus on their preparation, training and performance. We have every confidence ParalympicsGB athletes will produce performances to inspire and unite the nation once again.”
Randox, with almost 40 years of international diagnostics experience, has been at the forefront of COVID-19 testing since the outset of the pandemic. With proven testing capability and well-established logistics and customer support services, Randox are strongly placed to allow international travellers to travel with confidence.
For further information on Covid testing services please contact the Randox Covid Customer Support team on covidcustomersupport@randox.com or +44 (0) 28 9434 3005.
Want to know more?
Contact us or visit Randox Health.
Related COVID-19 Products and Services
HOME TEST
ANTIBODY TEST
TEST TO RELEASE
LABORATORY TOOLS
Randox Health teams up with Olympic Medallist Bianca Walkden to open COVID travel testing centre in Liverpool ONE
Tuesday 10 August 2021: Randox Health teams up with Olympic Medallist Bianca Walkden to open COVID travel testing centre in Liverpool ONE
A new COVID travel testing centre, from the UK’s leading diagnostics provider Randox Health, was officially opened this week by Taekwondo Olympic Bronze Medallist Bianca Walkden.
Located centrally in Chavasse Park in Liverpool ONE, the new facility has a capacity of more than 1500 appointments per day, making it the largest COVID travel testing centre in Liverpool.
The facility consists of an on-site testing laboratory and a walk-through sample collection centre where appointments, during which a trained collection officer takes the sample, take no longer than ten minutes.
David Ferguson, Randox Global Sales Director said;
“As the largest COVID-19 testing laboratory in Europe, with a capacity of over 500,000 tests per day, Randox is committed to the provision of reliable and affordable testing for international travel.
“Randox already has strong connections to the city of Liverpool having been the headline sponsor of the Randox Grand National for the last five years, and by setting up our newest testing centre in such a popular tourist destination as Liverpool ONE, we will ensure our service is as accessible as possible for both UK holidaymakers and those returning home after their visit to the city.
“We look forward to supporting their travel plans and making the testing process stress-free.”
The Randox Health testing facility at Liverpool ONE offers a range of asymptomatic testing services for both pre-departure and arrival testing requirements, including next-day Day 2 and Day 8 tests, antigen testing, and express services offering PCR test results in either 12 or 1-3 hours.
For the month of August Randox Health is also offering a £5 discount on all tests at Liverpool ONE.
Iain Finalyson, Liverpool ONE Estate Director, commented;
“Trusted by Team GB to deliver pre-departure and arrival testing for the Tokyo Olympic Games, Randox Health is renowned in the UK as a leading and reputable supplier of COVID-19 testing, and we are proud to partner with them to bring this service to Liverpool city centre.
“Visitors to Liverpool ONE can, at their convenience, take their test, and while they are waiting for their result, enjoy all that Liverpool ONE has to offer across shopping, dining and leisure.”
Bianca Walkden, Taekwondo Olympic Bronze Medallist;
“I am honoured to have the opportunity to officially open the Randox Health COVID travel testing centre in my hometown of Liverpool.
“Having used the service myself for Team GB’s pre-departure and Day 2 testing requirements pre and post the Olympic Games, I can vouch for the thorough testing and support Randox gave us to ensure we were prepared to arrive safely to the starting line in Tokyo.”
Randox, with almost 40 years of international diagnostics experience, has been at the forefront of COVID-19 testing since the outset of the pandemic. With proven testing capability and well-established logistics and customer support services, Randox are strongly placed to allow international travellers to travel with confidence.
Randox tests on offer
- Departures – PCR (1-3 hours) / (12 hours) / (next day) – £95 / £70 / £60
- Departures – Antigen – £39
- Arrivals – Day 2 – £60
- Arrivals – Day 8 package – £60
- Arrivals – Test to Release (12 – 16 hours) – £60
For more information or to book visit fly.randox.com
For further information on Covid testing services please contact the Randox Covid Customer Support team on covidcustomersupport@randox.com or +44 (0) 28 9434 3005.
For press enquiries please contact Amy Millar in the Randox PR team: randoxpr@randox.com
Want to know more?
Contact us or visit Randox Health.
Related COVID-19 Products and Services
HOME TEST
ANTIBODY TEST
TEST TO RELEASE
LABORATORY TOOLS
Statement on Randox COVID-19 dropbox service
09 August 2021: Logistics Update on Randox COVID-19 Testing for International Travel
A spokesperson for Randox said:
“Randox is constantly expanding and improving its COVID-19 testing capacity and associated logistics network, which is already the largest in the United Kingdom, to meet the rapidly growing demand resulting from the loosening of travel restrictions. Randox continues to increase the number of drop boxes across the United Kingdom, which already totals over 200, and is increasing the frequency of box collections which are already occurring multiple times per day. Randox is providing premium testing services in dynamic and rapidly changing circumstances and is committed to continuously improving its logistics network, to ensure that all international travellers receive their results in time.”
Press enquiries should be emailed to randox@newcenturymedia.co.uk